Jones from Spain

Registered at the short selling broker Skilling, 5 minutes ago.

» Try Skilling you too
69% of retail CFD accounts lose money.
Don't show again

AbbVie, Inc. (ABBV) shares information

Abbvie Inc

24h Change

0.41 %


Live rate: Market closed

Stock data per Monday 10 May, 2021

0.47 (+ 0.41%)
US Market is closed

Live Stock price in graph for Abbvie Inc (ABBV)

  • Latest Volume

    7,091,243 (4.16 %)

  • Volume prev. day


  • Avg. daily volume


  • Market cap


  • P/E ratio


  • Today high

    117.2 USD

  • Today low

    115.965 USD

  • 52 week high

    117.2 USD

  • 52 week low

    77.26 USD

  • YTD Change

    + 11.02 %

Quick links


Latest news about Abbvie Inc

Below you can find the most recent news posts about Abbvie Inc, primarily from US and UK based news sources.

Soliton Stock Rallies After $22.60/Share Buyout From AbbVie

Monday, 10 May 2021, 16:27:56
AbbVie Inc (NYSE: ABBV ) is making an opportunistic play to boost the aesthetics business by adding a long-delayed body sculpting product into the fold. AbbVie’s Allergan Aesthetics unit will pay $550 million in cash to scoop up Soliton Inc (NASDAQ: SOLY ) and Resonic, its sound-wave device that improves the appearance of cellulite. Under the terms of the transaction, Allergan Aesthetics will pay $22.60 per … Full story available on
— Benzinga

The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data

Tuesday, 4 May 2021, 14:10:20
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV ) BioNTech SE – ADR (NASDAQ: BNTX ) (moving on momentum imparted by vaccine news flow) GT Biopharma Inc (NASDAQ: GTBP ) GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH ) Lantheus Holdings Inc (NASDAQ: LNTH ) Orthopediatrics Corp (NASDAQ: KIDS ) Quest Diagnostics Incorporated (NYSE: DGX ) West Pharmaceutical Services, Inc. (NYSE: WST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows May 3) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Aptinyx Inc. (NASDAQ: APTX ) Atea Pharmaceuticals, Inc. (NASDAQ: AVIR ) AVROBIO, Inc. (NASDAQ: AVRO ) (reacted to the need for conducting a registrational trial for its gene therapy candidate for Fabry disease) Aziyo Biologics, Inc. (NASDAQ: AZYO ) Celyad Oncology SA (NASDAQ: CYAD ) Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX ) Cyclerion Therapeutics, Inc. (NASDAQ: CYCN ) Decibel Therapeutics, Inc.
— Benzinga

AbbVie Beats Q1 Earnings On Strong Humira Sales, Raises Full-Year Profit Forecast

Friday, 30 April 2021, 15:17:48
AbbVie Inc (NYSE: ABBV ) beat Wall Street consensus for first-quarter revenue & earnings and raised its full-year profit forecast, helped by demand for its rheumatoid arthritis drug, Humira, and newer treatments such as psoriasis treatment Skyrizi. It reported an adjusted EPS of $2.95, which beat the analyst consensus estimate of $2.83 Sales of $13.01 billion also surpassed the analyst consensus estimate of $12.76 billion and increased 50% over sales of $8.62 … Full story available on
— Benzinga

Abbvie Posts First-Quarter Earnings Beat and Raises Guidance – TheStreet

Friday, 30 April 2021, 14:03:49
AbbVie reports first-quarter earnings that beat expectations and raises its full-year outlook amid stronger-than-expected sales of its therapeutic drugs and treatments.
— The Street

AbbVie raises full-year profit forecast as Humira fuels sales beat

Friday, 30 April 2021, 13:55:28

Trading broker recommendation

We recommend that you check out as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: offer a large number of stocks for trading. Register an account today and check if they have ABBV available or trade one of the many other CFD stocks they have.
Risk warning: 71.2% of retail investor accounts lose money when trading CFDs with Capital.